Search results for "Platinum"

showing 10 items of 629 documents

CCDC 628062: Experimental Crystal Structure Determination

2007

Related Article: L.Vigo, M.Risto, E.M.Jahr, T.Bajorek, R.Oilunkaniemi, R.S.Laitinen, M.Lahtinen, M.Ahlgren|2006|Cryst.Growth Des.|6|2376|doi:10.1021/cg060348r

cis-Dichloro-bis(diphenylselenyl)-platinum(ii)Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Organometallic Complexes with Biological Molecules. Structural investigation of cis-diammineplatinum(II)-Porphyrin derivatives.

2009

cis-diammineplatinum(II) PorphyrinSettore CHIM/03 - Chimica Generale E Inorganica
researchProduct

Oxidative Stress and Cognitive Alterations Induced by Cancer Chemotherapy Drugs: A Scoping Review

2021

Cognitive impairment is one of the most deleterious effects of chemotherapy treatment in cancer patients, and this problem sometimes remains even after chemotherapy ends. Common classes of chemotherapy-based regimens such as anthracyclines, taxanes, and platinum derivatives can induce both oxidative stress in the blood and in the brain, and these effects can be reproduced in neuronal and glia cell cultures. In rodent models, both the acute and repeated administration of doxorubicin or adriamycin (anthracyclines) or cisplatin impairs cognitive functions, as shown by their diminished performance in different learning and memory behavioural tasks. Administration of compounds with strong antiox…

cognition0301 basic medicineAntioxidantPhysiologymedicine.medical_treatmentClinical BiochemistryReviewRM1-950Pharmacologymedicine.disease_causeBiochemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMedicine<i>N-</i>acetylcysteineDoxorubicinplatinumCaffeic acid phenethyl esterMolecular BiologyMesnaanthracyclinesCisplatinChemotherapybusiness.industryCancerclinical trialCell Biologymedicine.diseaseN-acetylcysteinetaxanes030104 developmental biologychemistry030220 oncology & carcinogenesisbiomarkerTherapeutics. PharmacologybusinessOxidative stressmedicine.drugAntioxidants
researchProduct

Electrocatalytic properties of manganese and cobalt polyporphine films toward oxygen reduction reaction

2018

International audience; Novel member of polymetalloporphines, namely manganese polymetalloporphine of type I (pMnP-I) obtained by ion exchange from magnesium polyporphine of type I (pMgP-I) is reported for the first time and compared to its cobalt analogue (pCoP-I). Both polymer films have been obtained via two-step procedure: demetaladon of the pMgP-I electrode film via its exposure to trifluoroacetic acid solution, resulting in formation of the metal-free polyporphine of type I (pH(2)P-I) followed by electrochemically induced incorporation of Co or Mn ions from the acetonitrile solution of cobalt and manganese perchlorates. A further oxidative transformation of pCoP-I, polymer films has l…

conjugated porphyrin polymerGeneral Chemical EngineeringInorganic chemistryFOS: Physical scienceschemistry.chemical_element02 engineering and technologyElectrolyteManganesepositive potentialsphthalocyanines010402 general chemistry01 natural sciencescatalystsAnalytical ChemistryCatalysisporphine[CHIM.ANAL]Chemical Sciences/Analytical chemistryframeworksElectrochemistry[CHIM]Chemical Sciencesdioxygen reductionCondensed Matter - Materials SciencemetalloporphyrinsAqueous solutionIon exchangeMagnesiumElectroactive polymersMaterials Science (cond-mat.mtrl-sci)Oxygen electroreductionelectropolymerizationfuel-cell cathode021001 nanoscience & nanotechnologyMetalloporphines0104 chemical sciencesPolymer film coated electrodechemistry0210 nano-technologyPlatinumCobaltMg(II) porphineJournal of Electroanalytical Chemistry
researchProduct

Incorporation of Pt(II) complex with [amino-2(methylthio)(1,2,4)triazole-(1,5-a)pyrimidine-6-carboxylic-acid] ligand in MCM41 for controlled release

2015

Drug carriers play a critical role for the loading and the release of the drug. A promising frontier is represented by a new class of innovative medicines that represents directional transport vehicles "drug delivery" and consist of assembled structures carrier (nano)-drug. Silica-based materials, nontoxic, biocompatible, have been used as adjuvant and excipient in pharmaceutical technology. In this class of compounds, the mesoporous materials, such as MCM41, SBA-15 and hexagonal mesoporous silica, have been investigated for medication and drug delivery due to their properties. In fact, these materials show a large specific pore volume made up of regular pores having a diameter in the nanom…

controlled release MCM41 platinum(II) complexes 29Si {1H} CP-MAS NMR.
researchProduct

Crystal structures of organoplatinum complexes containing alkyleugenoxyacetate and p-chloroaniline

2016

In the title trans-di­chlorido­platinum(II) complexes, the central PtII atom is further coordinated by the p-chloro­aniline N atom and ethyl­enic double bond of alkyl­eugenoxyacetate.

crystal structureDouble bondStereochemistryCrystal structure010403 inorganic & nuclear chemistryRing (chemistry)01 natural sciencesResearch Communicationstrans-dichloridoplatinum(II) complexeslcsh:Chemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicinep-chloroanilineGeneral Materials ScienceBenzenetrans-di­chlorido­platinum(II) complexesOrganoplatinumCoordination geometrychemistry.chemical_classificationHydrogen bondLigandp-chloro­anilineGeneral ChemistryCondensed Matter Physicshydrogen bonding0104 chemical sciencesCrystallographychemistrylcsh:QD1-999030220 oncology & carcinogenesisActa Crystallographica Section E: Crystallographic Communications
researchProduct

Crystal structures of two platinum(II) complexes containing ethyl eugenoxyacetate and 2-amino-pyridine.

2017

The synthesis and crystal structures of two platinum(II) complexes containing one or two Cl atoms, an eugenol derivative and 2-amino­pyridine as ligand are described. The central PtII atom displays a distorted square-planar coordination.

crystal structureDouble bondStereochemistryPopulationDihedral angle010402 general chemistry010403 inorganic & nuclear chemistryRing (chemistry)01 natural sciencesResearch Communicationschemistry.chemical_compoundPyridineGeneral Materials Science2-aminopyridineeducationchemistry.chemical_classificationeducation.field_of_studyCrystallographyChemistryHydrogen bondLigandAromaticity2-amino­pyridineGeneral ChemistryCondensed Matter Physics0104 chemical sciencesCrystallographyQD901-999eugenolplatinum(II) complexes
researchProduct

Crystal structure of chlorido-{4,5-dimeth-oxy-2-[(2,3-η)-2-prop-2-en-1-yl]phenyl-κC (1)}(piperidine-κN)platinum(II) ethanol monosolvate

2014

The title platinum(II) complex shows a trigonal–bipyramidal coordination and inter­molecular C—H⋯Cl, C—H⋯π and (C/O)—H⋯O hydrogen bonds.

crystal structureEthanolChemistryHydrogen bondchemistry.chemical_elementGeneral ChemistryCrystal structuremethyl­eugenolCondensed Matter Physicshydrogen bondingMedicinal chemistryResearch CommunicationsCrystallcsh:Chemistrychemistry.chemical_compoundmethyleugenollcsh:QD1-999General Materials SciencePiperidinePlatinumplatinum(II) complex
researchProduct

Crystal structure of tricarbonyl(μ-diphenylphosphido-κ2P:P)(methyldiphenylsilyl-κSi)bis(triphenylphosphane-κP)iron(II)platinum(0)(Fe—Pt)

2015

The title compound belongs to the large family of heterodinuclear phosphide-bridged complexes. The Fe—Pt bond is of 2.7738 (4) Å and there is an unprecedented arrangement of the silyl ligand in a trans-position with respect to the metal–metal vector in the family of phosphide-bridged iron–platinum heterobimetallics.

crystal structuremetal–metal bondSilylationStereochemistrychemistry.chemical_elementCrystal structureMedicinal chemistryResearch Communicationslcsh:Chemistrychemistry.chemical_compoundphosphido bridges[CHIM]Chemical SciencesGeneral Materials Sciencediphenylmethylsilyl ligandComputingMilieux_MISCELLANEOUSdi­phenyl­methyl­silyl ligandLigandTricarbonGeneral ChemistryCondensed Matter Physics3. Good healthiron complexeslcsh:QD1-999chemistryheterobimetallicsPlatinumplatinum complexesActa Crystallographica Section E Crystallographic Communications
researchProduct

CCDC 1868995: Experimental Crystal Structure Determination

2019

Related Article: Evgeny Bulatov, Matti Haukka|2019|Dalton Trans.|48|3369|doi:10.1039/C8DT03912G

dibromo-(2-{[bis(pyridin-2-yl)amino]methyl}benzonitrile)-platinum(ii)Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct